Bleeding-Related Episodes (BRE) in Patients With Immune Thrombocytopenia (ITP) Receiving Eltrombopag (EPAG) or Romiplostim (ROMI)- Real World Evidence from 26 US Institutions
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.834
https://www.valueinhealthjournal.com/article/S1098-3015(17)31168-3/fulltext
Title :
Bleeding-Related Episodes (BRE) in Patients With Immune Thrombocytopenia (ITP) Receiving Eltrombopag (EPAG) or Romiplostim (ROMI)- Real World Evidence from 26 US Institutions
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31168-3&doi=10.1016/j.jval.2017.08.834
First page :
A545
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
794